Related Experiment Videos
[Pharma-clinics. How I treat ... hypo- or hyperkalemia]
1Service Médecine Interne, CHU Ourthe-Amblève.
Revue Medicale De Liege
|May 10, 2000
Summary
Treatment for dyskalemia, including hypokalemia and hyperkalemia, prioritizes identifying the cause. Oral potassium supplements are preferred for moderate cases, while intravenous routes are for emergencies. Always investigate the underlying reason for potassium imbalances.
Area of Science:
- Nephrology
- Internal Medicine
- Clinical Pharmacology
Context:
- Dyskalemia, encompassing both hypokalemia and hyperkalemia, presents a common clinical challenge.
- Accurate diagnosis and management are crucial for patient outcomes, particularly in those with cardiac conditions.
Purpose:
- To outline the etiological and symptomatic treatment strategies for dyskalemia.
- To differentiate between oral and intravenous routes for potassium supplementation and correction.
Summary:
- The primary approach to dyskalemia involves identifying and addressing the underlying cause.
- Moderate hypokalemia (K < 3 mmol/l or 3.5 mmol/l with cardiac disease) requires oral potassium (K) supplements.
- Severe hyperkalemia (K > 7 mmol/l) necessitates immediate intravenous correction, followed by oral intervention if needed.
- Chronic or moderate hyperkalemia (K > 5.5 mmol/l) is best managed with oral treatments.
- Investigating drug-induced causes is fundamental in all dyskalemia cases.
Impact:
- Provides clear guidelines for managing potassium imbalances, improving clinical decision-making.
- Highlights the importance of etiological treatment, potentially reducing long-term complications.
- Emphasizes the appropriate use of different administration routes for potassium therapy based on severity and clinical context.